Show Summary Details
Page of

Liver disease and exogenous opioid pharmacokinetics1 

Liver disease and exogenous opioid pharmacokinetics1
Chapter:
Liver disease and exogenous opioid pharmacokinetics1
Author(s):

Mellar P. Davis

DOI:
10.1093/med/9780199236640.003.0003
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 05 April 2020

Chapter 3 discusses liver disease and exogenous opioid pharmacokinetics, and includes cholestasis and endogenous opioids, opioid receptor antagonists in liver failure, exogenous opioids and liver disease, pharmacokinetics of opioids in cirrhosis, cytochrome P450 (CYP) enzymes, individual CYP enzymes, conjugases, renal failure, and specific opioids.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.